Consistently, human cirrhotic tissue samples (Figure 1B; Figure S1B,C, Supporting Information) and mouse models of liver fibrosis induced by carbon tetrachloride (CCI4) and thioacetamide (TAA) (Figure S1D–I, Supporting Information) also revealed reduced SLC27A5 expression compared with that in the control trials. The gene discussed is SLC27A5; the disease is Hepatic fibrosis.